Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Harae Dx
AddedFeb 18, 2024
UpdatedJun 18, 2026
Harae Dx

Harae Dx

Harae Dx Corp.: Innovating portable, automated systems for early cancer detection.

HQ
Pleasanton, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Harae Dx Corp. was founded with the mission to revolutionize early cancer detection through innovative technology. The company has developed the world's smallest, portable, and automated multi-cancer detection system, focusing on accessibility and ease of use. Their core product, a compact and low-cost diagnostic device, utilizes a licensed panel of biomarkers to detect breast cancer at an early stage. Harae Dx aims to make early cancer detection more accessible and affordable, targeting both healthcare providers and patients globally.

Notable figures affiliated with Harae Dx include leading experts in medical diagnostics and biotechnology. The company has garnered attention from prominent investors in the health tech sector, contributing to its rapid development and deployment. Key achievements include the successful development and licensing of their biomarker panel, as well as regulatory approvals that underscore the system's accuracy and reliability. Harae Dx's impact lies in its potential to significantly improve early cancer detection rates, ultimately saving lives and reducing healthcare costs worldwide.

Harae Dx - Similar Companies

Aeena Dx logo

Aeena Dx

AOA Dx logo

AOA Dx

aoadx.com

Hera Diagnostics logo

Hera Diagnostics

Harbinger Health logo

Harbinger Health

Oncodea logo

Oncodea

oncodea.com

Micronoma logo

Micronoma

micronoma.com

Pharus Diagnostics logo

Pharus Diagnostics

pharusdx.com

AxonDx logo

AxonDx

axondx.com

GRAIL logo

GRAIL

grail.com

Early Detection logo

Early Detection

cancer.us

Breath Diagnostics logo

Breath Diagnostics

Hawkeye Bio logo

Hawkeye Bio

hawkeyebio.com

Naveris logo

Naveris

naveris.com

Thrive Earlier Detection logo

Thrive Earlier Detection

Earli logo

Earli

earli.com

Harae Dx - Quick Facts

Who are Harae Dx's competitors?

Companies similar to Harae Dx include Aeena Dx, AOA Dx, Hera Diagnostics and Harbinger Health.

When was Harae Dx founded?

Harae Dx was founded in 2021.

Where is Harae Dx's headquarters located?

Harae Dx's headquarters is located in Pleasanton, CA, US.

How much has Harae Dx raised to-date?

As of Dec 12, 2022, Harae Dx has raised a total of $350k (USD).

How many employees does Harae Dx have?

Harae Dx has 3 employees as of Feb 4, 2024.

Harae Dx - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Detection
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research